Ambrohist S Syrup 100Ml

AMBROHIST S SYRUP 100ML may interact with the following medicines:

• Xanthines such as aminophylline or theophylline: The concomitant use of xanthine derivatives with AMBROHIST S SYRUP 100ML may increase the risk of hypokalaemia and excessive stimulation of the cardiovascular system. Patients may experience palpitations, rapid heartbeat, tremors, nervousness, or irregular heart rhythm, especially at higher doses.
• Corticosteroids such as prednisolone: Concurrent use of corticosteroids with AMBROHIST S SYRUP 100ML may enhance potassium loss caused by beta2-agonist components. Severe potassium depletion may increase the risk of muscle weakness, cramps, fatigue, and cardiac rhythm disturbances.
• Diuretics such as furosemide or hydrochlorothiazide: The concomitant use of diuretics and AMBROHIST S SYRUP 100ML may further reduce potassium levels in the blood, particularly with non-potassium-sparing diuretics. This may increase the likelihood of weakness, dizziness, muscle cramps, or serious cardiac arrhythmias.
• Other sympathomimetic bronchodilators such as salbutamol or epinephrine: Using AMBROHIST S SYRUP 100ML together with other sympathomimetic agents may increase the risk of excessive cardiovascular stimulation. This may lead to side effects such as tachycardia, elevated blood pressure, palpitations, tremors, or chest discomfort.
• Monoamine oxidase inhibitors (MAOIs) such as phenelzine: The concomitant use of MAOIs with AMBROHIST S SYRUP 100ML may potentiate sympathomimetic effects and significantly increase the risk of hypertension, severe headache, tachycardia, or cardiac arrhythmias. This combination should generally be avoided unless specifically advised by a doctor.
• Tricyclic antidepressants such as amitriptyline: Tricyclic antidepressants may enhance the cardiovascular stimulant effects of AMBROHIST S SYRUP 100ML. Concurrent use can increase the risk of elevated heart rate, hypertension, palpitations, and potentially serious cardiac rhythm abnormalities.

AMBROHIST S SYRUP 100ML may interact with diseases, including:

• Cardiovascular disease: AMBROHIST S SYRUP 100ML should be used cautiously in patients with cardiovascular disorders, as terbutaline may increase heart rate and cardiac workload. It may worsen conditions such as arrhythmias, angina, or uncontrolled hypertension and may increase the risk of palpitations or chest discomfort.
• Hyperthyroidism: Patients with hyperthyroidism may show increased sensitivity to beta2-agonists present in AMBROHIST S SYRUP 100ML. This may enhance adverse effects such as tremors, nervousness, rapid heartbeat, and excessive cardiovascular stimulation.
• Peptic ulcer disease: AMBROHIST S SYRUP 100ML should be used with caution in individuals with peptic ulcer disease, as ambroxol may occasionally irritate the gastric lining. This may aggravate symptoms such as stomach pain, acidity, nausea, or gastric discomfort in susceptible patients.

The recommended dose of AMBROHIST S SYRUP 100ML should be taken as directed by your doctor. The dosage depends on the severity of symptoms and individual response.

The recommended dose of AMBROHIST S SYRUP 100ML should be taken as directed by your doctor. The dosage depends on the severity of symptoms and individual response.

If you miss a dose of AMBROHIST S SYRUP 100ML, take it as soon as you remember. If it is close to the next dose, skip the missed dose and continue with your regular schedule.